Skip to content

Sleep Disturbances in Moderate to Severe Chronic Obstructive Pulmonary Disease

Looking at sleep disturbances in moderate to severe Chronic Obstructive Pulmonary Disease (COPD) patients by performing a polysomnogram

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12610000596000
Acronym
Sleep in COPD
Enrollment
30
Registered
2010-07-23
Start date
2010-08-13
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Patients with chronic obstructive pulmonary disease (COPD) have previously been shown to complain of poor sleep, daytime fatigue and sleepiness. This has been seen in large studies based on questionnaires, however a US study of over 2,000 participants with mild COPD found little sleep disturbance. This study will measure sleep quality and symptoms of sleep disturbance in a group of participants with moderate to severe COPD and correlate perceived with actual sleep disturbance. Thirty participants with moderate to severe COPD (defined as at least 1 standard deviation below the lower limit of their predicted function) will complete questionnaires measuring quality of life, symptoms of respiratory and sleep disturbance and daytime sleepiness. They will be required to have a stable regimen of treatment for their lung disease and no significant medical or psychological conditions which could prevent them completing the study. Standard clinical spirometry will be performed and an in-laboratory sleep study carried out. This sleep study will monitor sleep, airflow, oxygen and carbon dioxide (CO2) levels during the night, as accumulation of CO2 during the night in these patients may contribute to sleep disruption and fragmentation. Participants will be asked to describe the quality of their sleep and this will be compared to the measured sleep, as sleep perception is thought to be poor in these patients. The outcomes of the study will be a description of sleep architecture, including the number of changes in sleep stage. It is thought that sleep stage transitions are important for daytime sleepiness. The degree of sleep fragmentation will be correlated with the sleep questionnaire outcomes and also with the severity and other measures of the respiratory function.

Interventions

Polysomnogram to observe the sleep architecture of COPD patients. Duration of observation is overnight (6pm on the first day to 7am the next morning)

Sponsors

University of Melbourne
Lead SponsorUniversity

Eligibility

Sex/Gender
All
Age
40 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

Previous diagnosis of COPD Forced expiratory volume in 1 second (FEV1)/Forced vital capacity(FVC) below lower limit of normal range Forced expiratory volume in 1 second(FEV1) less than 70% mean predicted value Body Mass Index less than or equal to 33 10 pack year history of smoking

Exclusion criteria

Change in COPD medication within past 30 days Previously diagnosed or treated sleep disordered breathing Significant neurological, psychological or psychiatric co-morbidities Unable to refrain from caffeine from 4pm on night of sleep study Unable to refrain from cigarettes during overnight stay (6pm to 7am the following day) Unable to refrain from alcohol from 12pm on day of sleep study

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026